SHPG - Shire plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
164.37
+3.63 (+2.26%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close160.74
Open160.08
Bid163.00 x 100
Ask165.00 x 100
Day's Range159.81 - 166.00
52 Week Range123.73 - 192.15
Volume4,194,542
Avg. Volume1,493,636
Market Cap49.129B
Beta1.47
PE Ratio (TTM)11.71
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield1.05 (0.69%)
Ex-Dividend Date2018-03-08
1y Target EstN/A
Trade prices are not sourced from all markets
  • Takeda Raises Bid for Shire to Over $60 Billion
    Bloomberg Videoyesterday

    Takeda Raises Bid for Shire to Over $60 Billion

    Apr.20 -- Takeda Pharmaceutical Co. plans to sweeten its offer for drugmaker Shire Plc to more than $60 billion after a prior bid was rejected, according to people with knowledge of the matter. Les Funtleyder, portfolio manager at E Squared Capital Management, speaks with Bloomberg's Vonnie Quinn on "Bloomberg Markets."

  • Takeda increases bid for Shire
    CNBC Videosyesterday

    Takeda increases bid for Shire

    CNBC’s David Faber reports that Japanese drug company Takeda is increasing its proposal for Shire.

  • The Wall Street Journal13 hours ago

    [$$] Takeda Increases Takeover Proposal for Drug Rival Shire

    Japan’s Takeda said it had made a sweetened proposal to buy Shire after its three previous bids for the rival drugmaker that has drawn broader interest across the sector were rejected.

  • Investopedia22 hours ago

    Allergan Declines to Bid on Shire

    Botox maker Allergan said it will no longer consider bidding for Shire.

  • Shire Brouhaha Continues As Takeda Sweetens Its Fourth Proposal
    Investor's Business Daily22 hours ago

    Shire Brouhaha Continues As Takeda Sweetens Its Fourth Proposal

    The brouhaha surrounding Shire continued Friday after Takeda made a fourth bid to buy the drugmaker, sweetening the pot from an earlier bid that valued the company around $61 billion.

  • Japan's Takeda sweetens $62 billion Shire offer
    Reuters23 hours ago

    Japan's Takeda sweetens $62 billion Shire offer

    TOKYO/LONDON (Reuters) - Japan's Takeda Pharmaceutical nudged up its offer for Shire to 44.3 billion pounds ($62 billion) on Friday to try to persuade the rare-disease drugs specialist into talks after it rejected three previous proposals. Japan's biggest drugmaker increased its potential cash and shares bid to 47 pounds a share, up 1 percent from its previous proposal of 46.50 pounds. It also lifted the cash component by 3.25 pounds to 21 pounds a share, a shift that analysts said was needed to appeal to Shire's shareholders.

  • Reuters23 hours ago

    Japan's Takeda sweetens $62 billion Shire offer

    TOKYO/LONDON (Reuters) - Japan's Takeda Pharmaceutical nudged up its offer for Shire (SHP.L) to 44.3 billion pounds on Friday to try to persuade the rare-disease drugs specialist into talks after it rejected three previous proposals. Japan's biggest drugmaker increased its potential cash and shares bid to 47 pounds a share, up 1 percent from its previous proposal of 46.50 pounds. It also lifted the cash component by 3.25 pounds to 21 pounds a share, a shift that analysts said was needed to appeal to Shire's shareholders.

  • Shire (SHPG) Turns Down Takeda's Third Buyout Proposition
    Zacksyesterday

    Shire (SHPG) Turns Down Takeda's Third Buyout Proposition

    Shire (SHPG) declines Takeda Pharmaceutical's third acquisition offer in a cash-stock deal.

  • MarketWatchyesterday

    FTSE 100 ends at 11-week high as pound falls on BOE rate-hike doubts

    U.K. stocks on Friday advance for a fourth straight day, closing at the highest level in about 11 weeks, partly prompted by a drop in the pound after Bank of England Gov. Mark Carney suggested that an ...

  • Takeda Said to Consider Raising Bid for Shire
    Bloombergyesterday

    Takeda Said to Consider Raising Bid for Shire

    Takeda Pharmaceutical Co. plans to sweeten its offer for drugmaker Shire Plc to more than $60 billion after a prior bid was rejected, according to people with knowledge of the matter. Les Funtleyder, portfolio ...

  • Takeda raises offer for Shire for a fourth time to £42.8bn
    The Telegraphyesterday

    Takeda raises offer for Shire for a fourth time to £42.8bn

    Takeda raises offer for Shire for a fourth time to £42.8bn

  • Reutersyesterday

    Takeda weighs raising Shire bid to more than 47 stg/share: sources

    Japan's Takeda Pharmaceutical Co Ltd is considering raising its cash-and-stock bid for London-listed drug maker Shire Plc to approximately 47 pounds per share or more, people familiar with the matter said ...

  • Reutersyesterday

    Takeda weighs raising Shire bid to more than 47 pounds per share - sources

    (Reuters) - Japan's Takeda Pharmaceutical Co Ltd is considering raising its cash-and-stock bid for London-listed drug maker Shire Plc (SHP.L) to approximately 47 pounds per share or more, people familiar ...

  • Takeda Adds More Cash in Boosting Shire Bid Over $60 Billion
    Bloombergyesterday

    Takeda Adds More Cash in Boosting Shire Bid Over $60 Billion

    Takeda Pharmaceutical Co. sweetened its offer for drugmaker Shire Plc to more than $60 billion after three prior bids were rejected, wooing investors in the U.S. company with a higher cash component.

  • Market report: Shire dives as takeover by Japan’s Takeda looks dead in the water
    Evening Standardyesterday

    Market report: Shire dives as takeover by Japan’s Takeda looks dead in the water

    Shares in Shire were on the slide on Friday as the chatter on the trading floors was that a takeover of the pharmaceuticals giant is now doomed. Shire said yesterday afternoon that it had rejected three offers from Takeda of Japan, and that triggered the revelation that US firm Allergan had also taken a look but decided against making an offer. Shire says it wants to keep talking but traders believe enough is enough, and Takeda would struggle to put together a bigger offer.

  • Financial Timesyesterday

    [$$] Shire shares down 3.7% after Allergan rules out bid

    Allergan had made it known that it had contemplated an offer but then decided against it, which sent Shire’s share price down at 3,823 pence from yesterday’s close at 3,831 pence. Takeda shares fell by 4.67 per cent. Shire on Friday confirmed that Allergan had backed away.

  • Financial Timesyesterday

    [$$] Takeda sweetens offer for rival Shire to £42.8bn

    Shire has said it is “considering” its response to an improved offer from Takeda, after the Japanese pharmaceutical group sweetened its approach to the Dublin-based rare diseases company by roughly £455m on Friday.

  • Shire Rebuff May Not Dim Takeda's Appetite for $60 Billion Deal
    Bloombergyesterday

    Shire Rebuff May Not Dim Takeda's Appetite for $60 Billion Deal

    Three years ago, Christophe Weber made waves in Japan when 237-year-old Japanese drugmaker Takeda Pharmaceutical Co. named him its first foreign chief. These days, he’s in the hot seat for his controversial ...

  • The Wall Street Journalyesterday

    [$$] Fast-Growing Shire Had Pharmaceutical Rivals in a Takeover Frenzy

    Drugmaker Shire rebuffed a takeover bid from rival Takeda Pharmaceutical, then Allergan took a look.

  • The Wall Street Journalyesterday

    [$$] Third Time Unlucky for Takeda and Shire

    Shire has rejected Takeda’s three offers to buy it, and there may not be much more wiggle room to sweeten the bid.

  • Financial Times2 days ago

    [$$] Takeda sweetens bid for Shire to £42.8bn

    Japanese pharmaceutical group Takeda sweetened its offer for rival Shire by roughly £455m on Friday and shifted a significant portion of its proposal from stock to cash in a bid to win over the board of ...

  • Shire to World: Let the Bidding Begin
    Motley Fool2 days ago

    Shire to World: Let the Bidding Begin

    Takeda's made three offers to acquire Shire in the past month. Now a new bidder is emerging for the U.K. biopharma.

  • Reuters2 days ago

    PRESS DIGEST- Financial Times - April 20

    - Brunswick founder Alan Parker resigned as chair of Save the Children after current and former employees criticised his handling of sexual harassment at the charity. - Shire Plc rejected a 42.4 billion pound takeover offer from Japanese rival Takeda Pharmaceutical Co Ltd and Botox-maker Allergan Plc disclosed it had considered a run at the company but said it "does not intend to make an offer for Shire".

  • Reuters2 days ago

    PRESS DIGEST- Financial Times - April 20

    - Brunswick founder Alan Parker resigned as chair of Save the Children after current and former employees criticised his handling of sexual harassment at the charity. - Shire Plc rejected a 42.4 billion pound takeover offer from Japanese rival Takeda Pharmaceutical Co Ltd and Botox-maker Allergan Plc disclosed it had considered a run at the company but said it "does not intend to make an offer for Shire".

  • Reuters2 days ago

    PRESS DIGEST- British Business - April 20

    The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy. The Times Ultra Electronics Holdings Plc has ...